Autor:	Carlos Polanco Sánchez, Laura García Jurado, Ángel Sanz Granda
Rok vydání:	2012
Předmět:	medicine.medical_specialty Letter to the editor business.industry Health Policy Multiple sclerosis First line Disease Cost-effectiveness analysis medicine.disease Dermatology Immunology medicine Glatiramer acetate business medicine.drug
Zdroj:	Journal of Medical Economics. 15:1051-1053
ISSN:	1941-837X 1369-6998
DOI:	10.3111/13696998.2012.691928
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::2596804158ccd952fdce3d90d1caff9b https://doi.org/10.3111/13696998.2012.691928 Zobrazit plný text záznamu